Leaflet TIGECICLINA DEPO MED 50mg powder infusion solution


Indicated for: bacterial infections

Route of administration: infusion

Substance: tigecycline (tetracycline antibiotic)

ATC: J01AA12 (Antiinfectives for systemic use | Tetracyclines)

Tigecycline is an antibiotic from the glycylcycline class used for the treatment of complicated bacterial infections, including intra-abdominal infections, skin and soft tissue infections, and hospital-acquired pneumonia. It works by inhibiting bacterial protein synthesis and has a broad spectrum of activity against gram-positive, gram-negative, and anaerobic bacteria.

The medication is administered intravenously, as directed by a doctor, and the dosage is adjusted based on the severity of the infection and the patient's condition. It is primarily used for infections caused by bacteria resistant to other antibiotics.

Patients should be monitored for potential side effects, such as nausea, vomiting, diarrhea, or injection site reactions. It is important for patients to inform their doctor of any unusual symptoms.

Common side effects include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, severe reactions such as pancreatitis or superinfections may occur. Patients should be informed of these risks before starting treatment.

General data about TIGECICLINA DEPO MED 50mg

  • Substance: tigecycline
  • Date of last drug list: 01-03-2025
  • Commercial code: W70893001
  • Concentration: 50mg
  • Pharmaceutical form: powder infusion solution
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: LABORATORIOS NORMON S.A. - SPANIA
  • Holder: DEPO MED SRL - ROMANIA
  • Number: 15813/2025/01
  • Shelf life: 2 years-After packaging for sale;after reconstituting the solution- it is used immediately

Concentrations available for tigecycline

  • 10mg/ml
  • 50mg